Who can you meet at the Gross-to-Net Accounting Forum?

The Gross-to-Net Accounting Forum is less than a month away, taking place June 17-18 in Boston. Demand from small to mid-size pharma companies has been extremely high, indicating how timely and relevant GTN content is to your business—and bottom line.

As in most industries, small to mid-sized biopharmaceutical manufacturers have different challenges from their larger counterparts. In the Gross-to-Net space, while larger companies have a variety of people across several functions involved in the process, smaller companies make do with far fewer resources. Join the following small-mid size companies that are coming to GTN to find the solutions to their problems and yours alike:

•	Actient	•	Leo Pharma
•	AMAG	•	Neos Therapeutics
•	ARIAD	•	Purdue
•	Covidien	•	Salix
•	Exelixis	•	Shionogi Inc.
•	Forest Laboratories	•	Sunovion
•	Grifols	•	Vertex
•	Jazz Pharmaceuticals	•	Vertical / Trigen

Attend these spotlight sessions to help your bottom line: 

• Process Evaluation for Small to Mid-Sized Pharmaceutical Companies
• Benchmark Your Gross-to-Net Processes, Systems & Methodologies: Top 10 GTN Hot Topics
• Account for the Government Pricing and Contracting Impact on Gross-to-Net Calculations
• Commercial Contracts and Gross-to-Net for Managed Care

To view our full program, download our brochure.

As a reader of the Healthcare Insights Blog you get a 15% discount off the standard rate when using code XP1811BLOG to register. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

We look forward to seeing you next month!

Best,
The Pharmaceutical Accounting, Financial, & Reporting Team

Visit our Homepage
Follow us on Twitter

Session Spotlight: Understand the Relationship Between Chargebacks for Commercial vs. Government Pricing and Contracting Departments

Chargebacks seem relatively simple and straightforward. Acquisition price to the wholesaler less contract price totals the chargeback dollars, but what are some of the nuances of chargebacks in different market segment? Do they ever overlap? Why is validation so important?

Session: Understand the Relationship Between Chargebacks for Commercial vs. Government Pricing and Contracting Departments

Speaker: Annamarie Lee, Associate Director, Government Reporting & Commercial Contract Compliance, UPSHER-SMITH LABORATORIES.

The pharmaceutical chargeback/rebate process is a simple concept that quickly becomes complicated amongst evolving contracting strategies, data inconsistences and communication challenges. Add to that having to adjust to the nuances of chargebacks in different market segments and you have a process that can get overwhelming. In this session attendees will learn the importance of chargeback validation to avoid liabilities, the differences between government and commercial customer bases and how they may overlap.

Want to learn more? Download our brochure.

The Gross-to-Net Accounting Forum takes place June 17-18 in Boston, MA. As a reader of this blog you'll receive 15% off the standard rate by using code XP1811BLOG when you register. We look forward to seeing you this June!

Session Spotlight: Gross-to-Net Nirvana: Closing the Gap between Excel and ERP

Many pharmaceutical manufacturers have learned the hard way that ERP systems cannot handle the complexity and data processing requirements necessary for challenging contract incentive payments. So what is the solution? 

Session: Gross-to-Net Nirvana: Closing the Gap between Excel and ERP

Speakers: Jon Brier, Product Line Manager, Life Sciences, REVITAS
Pete Leddy, Product Line Manager, Analytics, REVITAS  

Pharmaceutical manufacturers often wonder if they have an alternative to Excel, which can be prone to data corruption, lacks the audit trail necessary to prove compliance, and is difficult to maintain over time. This session examines alternative analytics for your ERP system, the complexities of rate calculations, and the role of historical data and contract terms for accurate accruing.  

Want to learn more? Download the brochure. 

The Gross-to-Net Accounting Forum takes place June 17-18 in Boston, MA. As a reader of this blog you'll receive 15% off the standard rate by using code XP1811BLOG when you register. We look forward to seeing you this June!

Your Webinar Invitation: Gross-to-Net Forecasting and Reporting Impacts

Pharmaceutical Gross-to-Net professionals are managing a dynamic environment with government legislation, commercial contracting demands and accounting/compliance standards.

 This Complimentary Webinar Will Address Key GTN Hot Topics:

· New Product Launch Revenue Recognition and Forecasting GTN
· Acquisition of Product — GTN processing, accounting and forecasting transition plans
· Returns Reserve — Critical considerations before you calculate
· Returns Reserve — Best Practice Methodologies
· Late Stage Product Accounting & Forecasting considerations
· LOE Reserve — Demand, Pipeline, Returns accrual adjustments

You will hear from GTN Forum advisors David Levi from Bristol-Myers Squibb and Jennifer Sharpe from Professional Provider Services, Inc. Together, David and Jen will pool their personal experience, network of clients and industry colleagues to provide the audience with best practices and an interactive discussion on these key product milestones.

Space is limited, reserve your seat today.

DATE: May 8, 2013
TIME: 11:00am-12pm EST
SPEAKERS: David Levi Executive Director Finance US Controller & Global Commercial Controls, Bristol-Myers Squibb

Jennifer Sharpe Director of Managed Markets Projects & Business Development, Professional Provider Services, Inc.

COST: Complimentary

To find out more about the 2013 program, download the agenda.

As a reader of Healthcare Insights blog, you get a 15% discount off the standard rate when using code XP1811BLOG to register. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

We look forward to seeing you this June!

Best,

The Pharmaceutical Accounting, Financial, & Reporting Team

Visit our homepage
Follow us on Twitter

The Gross-to-Net Account forum will be here before you know it—seats are already filling up!

Since its introduction, the buzz for this event has been building more and more each week, with positive feedback from our growing attendee list.

Join us to ensure you do not miss out on learning the newest developments in the GTN process. Plus, this is a great opportunity to meet our distinguished 2013 GTN speaker faculty, and receive one-to-one help to develop operational strategies that will minimize the variances impacting your bottom line, including:

· Commercial Contracts and Managed Care - Tara Brodo, Director, Contract and Analytics, DAIICHI SANKYO

· Case Study: Budgeting, Planning, Accounting & Financial Controls Impact of Government - Brett Nussbaum, Head, Revenue Deductions, NOVARTIS

· Impact of Government Pricing and Contracting - Jennifer Norton Sr. Pricing & Contract Administration, VERTEX PHARMACEUTICALS

· Small/Mid-Sized Pharma Perspective for GTN Calculations - Paul Troiano Sr. Director, Commercial Finance, OPTIMER PHARMACEUTICALS

To find out more about the 2013 program, download the agenda.

 As a reader of this blog, you get a 15% discount off the standard rate when using code XP1811BLOG to register. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

We look forward to seeing you this June!

Best,
The Gross-to-Net Accounting Forum Team

P.S. Don’t forget to register for our Webinar taking place: May 8th 11:00-12:00 PM EST. Space is limited. Reserve your Webinar seat now!

Register today for the Gross-to-Net Accounting Forum

Ensuring your Gross-to-Net calculations are accurate is a messy business, but a necessary one. In the GTN space, the pharmaceutical industry has just recently begun to open up about forecasting and accruing for liability or working interdepartmentally between the commercial and government sectors.

At IIR’s Gross –to-Net Accounting Forum for Manufacturers we know how important it is for you to be able to benchmark your systems and methodologies against best practices. For that reason, we have developed unique formats whereby our session leaders and our audience interact before and during the event to ensure your most pressing GTN questions are answered when you are in Boston.

Some of these interactive session highlights include:

• Top 10 GTN Hot Topics to Benchmark Your Gross-to-Net Processes, Systems & Methodologies:  This valuable benchmarking exercise focuses on GTN organization/process design, system implementation, contract analytics, performance monitoring, contract forecasting, accruals, SOP/SOX documentation and management reporting. A live, dynamic audience poll on hot topics as well as industry case studies will get you “in the know” with how your peers are getting to their calculations.

• How Big Pharma Is Managing Gross-to-Net Processes : If you did not know there was a GTN Best Practices Industry Group, you do now! This session will highlight the latest best practice results, providing the attendees with guidance to take home and add to their GTN strategies. Interactive dialogue ensures no topic is left without a discussion.

To find out more about the 2013 program, download the agenda.

As a reader of Gross-to-Net blog, you get a 15% discount off the standard rate when using code XP1811BLOG to register. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

We look forward to seeing you this June!

Best,
Gross-to-Net Forum Team

Visit our homepage
Follow us on Twitter